drugset / Trial / NCT03597867
PGE2 Levels in Patient Treated With NSAIDs
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to determine vitreous levels of nonsteroidal antinflammatory drugs (NSAIDs) and prostaglandinE2 (PGE2) in eyes scheduled for vitrectomy. All patients received the study drugs for 3 days before surgery. 0.5 to 1.0 mL of undiluted vitreous was removed using the vitreous cutter positioned in the midvitreous cavity. Samples were immediately frozen and stored at -80°C until analysis. Sample analyses were performed using an high-performance liquid chromatography system. The lower limit of quantitation was 0.8 ng/mL. PGE2 levels were analyzed using the Prostaglandin E2 Monoclonal EIA Kit (Cayman Chemical Company) according to the manufacturer's instructions.
Timeline
- Start
- 2018-04-25
- Primary completion
- 2018-07-05
- Completion
- 2018-07-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bromfenac | Other / unclassified | 0.09 % | Topical |
| Subject | Diclofenac | Other / unclassified | 0.1 % | Topical |
| Subject | Indomethacin | Small molecule | 5 mg/ml | Topical |
| Subject | Nepafenac | Other / unclassified | 0.3 % | Topical |
Indications
No indication recorded.